Preparation method of biosynthesis silver nanoparticles
A silver nanoparticle, biosynthesis technology, applied in the field of medicine, can solve the problems of insufficient understanding of the synthesis mechanism, weak targeting, unfavorable application research, etc., to improve synthesis efficiency, high biocompatibility, and overcome drug resistance. Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0028] The invention provides a technical solution: a method for preparing biosynthetic silver nanoparticles, comprising the following steps:
[0029] S1: set 10 7 A HepG2 cell was injected into the nude mouse from the ventral groove of the nude mouse, and a nude mouse model of drug-resistant liver cancer was constructed;
[0030] S2: Isolate T cells from 0.5 mL of blood, and expand culture in 10 mL of culture medium;
[0031] S3: set 10 5 The cells were co-cultured with 0.1 mg silver nitrate in 10 mL medium, and then separated and purified by ultra-high-speed gradient centrifugation (100000 g) and HPLC (flow rate 0.1 mL / min, C18 column) to obtain silver nanoparticles. With near-infrared fluorescence characteristics, serum albumin (Serum albumin, SA) with a molecular mass of 66547 is adsorbed on the surface.
Embodiment 2
[0033] The present invention provides a technical solution: a preparation of biosynthetic silver nanoparticles loaded with microRNA, comprising the following steps:
[0034]S1: Since the surface of biosynthesized silver nanoparticles has been coated with SA, the disulfide bond in SA can be opened by reducing agent, so that it is in an open state;
[0035] S2: Embedding microRNA in it by stirring at a controlled speed;
[0036] S3: After ultra-high-speed separation, the silver nanoparticles loaded with microRNA were precipitated, the supernatant was discarded, and resuspended in water. In water with a low concentration of reducing agent, the disulfide bonds in SA were automatically closed, and the microRNA was encapsulated; When the microRNA silver nanoparticles were in a high-concentration GSH environment, the disulfide bond in SA would automatically open and release the drug.
[0037] Among them, the biosynthetic silver nanoparticles were characterized, and the size of the b...
Embodiment 3
[0039] The present invention provides a technical solution: a preparation of miR-122-loaded biosynthetic silver nanoparticles, comprising the following steps:
[0040] S1: Use the reducing agent glutathione to open the disulfide bond in SA to make it open;
[0041] S2: embedding miR-122 in it by stirring at a controlled speed;
[0042] S3: After ultra-high-speed separation, the silver nanoparticles loaded with miR-122 were precipitated, the supernatant was discarded, and water was added to resuspend. Under the condition of low concentration of GSH, the disulfide bond in SA was automatically closed, and miR-122 was encapsulated ; and when the miR-122-loaded silver nanoparticles were placed in a high-concentration GSH environment in liver cancer cells, the disulfide bond in SA would automatically open and release miR-122.
PUM
| Property | Measurement | Unit |
|---|---|---|
| size | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More 


